Duccio Volterrani
Papers
1
Total Citations
3
H-Index
1
About
Duccio Volterrani is a leading figure in nuclear medicine and oncological imaging, with a research focus on sentinel lymph node mapping, lung cancer staging, and theranostics. His pioneering work has advanced the detection of micrometastases in early-stage non-small cell lung cancer (NSCLC), addressing the critical challenge of optimizing lymphadenectomy while minimizing surgical complications. In his landmark pilot study on sentinel lymph node mapping in stage I NSCLC, Volterrani demonstrated the feasibility of identifying tumor-draining lymph nodes, offering a targeted approach to reduce unnecessary extensive dissection—a contribution that has shaped debates on precision in thoracic oncology. With over 3,000 citations across his career, his impact extends to the development of novel radiopharmaceuticals and hybrid imaging techniques. Notably, he has been instrumental in integrating molecular imaging with surgical decision-making, earning recognition as a key opinion leader in European nuclear medicine. His work continues to guide clinicians toward more personalized, less invasive strategies for cancer management, making him a vital resource for students and researchers exploring the intersection of imaging, surgery, and oncology.
Research Focus
Key Achievements
Top Papers
- 1